Medicare Enrolled
Dr. David Robertson, M.D.
Endocrinology · Atlanta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Robertson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Robertson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Robertson
Dr. David Robertson is an endocrinology specialist in Atlanta, GA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Robertson performed 10,739 Medicare services across 3,784 unique beneficiaries.
Between the years covered by Open Payments, Dr. Robertson received a total of $1,590,817 from 80 pharmaceutical and/or device companies across 2954 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Robertson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 5% volume in GA
$1,590,817 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,739
Medicare services
Top 5% in GA for endocrinology
3,784
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~511 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 4,020 | $18 | $45 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,166 | $88 | $270 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
749 | $9 | $50 |
| Blood glucose test using reagent strip A test that measures the level of sugar in the blood using a chemical reagent strip. |
554 | $5 | $20 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
488 | $9 | $50 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
481 | $16 | $78 |
| Free T3 thyroid hormone test A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning. |
385 | $17 | $160 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
361 | $38 | $95 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
339 | $10 | $50 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
304 | $61 | $175 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
298 | $25 | $110 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
256 | $13 | $80 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
143 | $63 | $200 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
141 | $6 | $105 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
136 | $11 | $125 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
125 | $5 | $35 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
107 | $29 | $100 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
104 | $3 | $10 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
97 | $8 | $40 |
| Kidney function blood test panel | 76 | $9 | $80 |
| Total cortisol level test A blood test that measures the total amount of cortisol hormone in your body. Cortisol is a hormone produced by the adrenal glands. |
74 | $16 | $250 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
71 | $99 | $305 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
58 | $15 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $112 | $375 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
45 | $125 | $360 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
44 | $25 | $165 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
21 | $126 | $500 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
18 | $40 | $230 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
17 | $38 | $200 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
15 | $50 | $105 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,590,817
Total received (2018-2024)
Avg $227,260/year across 7 years
Top 1% in GA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
2,954
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,510,475 (94.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$45,010 (2.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$35,332 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$101,121
2023
$110,903
2022
$177,824
2021
$131,484
2020
$275,505
2019
$391,650
2018
$402,330
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$63,797
Acella Pharmaceuticals, LLC
$11,231
Novo Nordisk Inc
$11,056
SANOFI-AVENTIS U.S. LLC
$5,634
AstraZeneca Pharmaceuticals LP
$3,899
Corcept Therapeutics
$2,540
Boehringer Ingelheim Pharmaceuticals, Inc.
$720
Amgen Inc.
$356
Novartis Pharmaceuticals Corporation
$229
Xeris Pharmaceuticals, Inc.
$220
BETA BIONICS, INC.
$219
Abbott Laboratories
$215
Amneal Pharmaceuticals LLC
$152
Radius Health, Inc.
$121
Madrigal Pharmaceuticals
$98
Averitas Pharma Inc.
$94
Dexcom, Inc.
$66
Insulet Corporation
$55
RECORDATI_RARE_DISEASES_INC.
$55
Embecta Corp.
$40
Esperion Therapeutics, Inc.
$36
Alexion Pharmaceuticals, Inc.
$35
IBSA Pharma Inc.
$34
Astellas Pharma US Inc
$30
Nevro Corp.
$24
Bayer Healthcare Pharmaceuticals Inc.
$21
Neurocrine Biosciences, Inc.
$21
Amphastar Pharmaceuticals, Inc.
$21
Kyowa Kirin, Inc.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Chiesi USA, Inc.
$16
Ascendis Pharma Inc
$15
Currax Pharmaceuticals LLC
$15
ABBVIE INC.
$13
CeQur Corporation
$12
Top 3 companies account for 85.1% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$562,027
AstraZeneca Pharmaceuticals LP
$498,203
Novo Nordisk Inc
$265,266
Boehringer Ingelheim Pharmaceuticals, Inc.
$116,379
Amgen Inc.
$51,182
Acella Pharmaceuticals, LLC
$33,167
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$11,874
Novo Nordisk AS
$11,720
Bayer HealthCare Pharmaceuticals Inc.
$11,570
SANOFI-AVENTIS U.S. LLC
$6,286
Corcept Therapeutics
$3,074
Bayer Healthcare Pharmaceuticals Inc.
$2,708
Tandem Diabetes Care, Inc.
$2,674
Regeneron Pharmaceuticals, Inc.
$1,550
AbbVie, Inc.
$1,534
Abbott Laboratories
$1,396
Ortho Dermatologics, a division of Bausch Health US, LLC
$1,009
Insulet Corporation
$987
Roche Diabetes Care, Inc.
$854
Xeris Pharmaceuticals, Inc.
$521
Amneal Pharmaceuticals LLC
$471
Amarin Pharma Inc.
$443
Novartis Pharmaceuticals Corporation
$434
Horizon Therapeutics plc
$427
Medtronic MiniMed, Inc.
$352
Bigfoot Biomedical Inc
$279
Becton, Dickinson and Company
$266
IBSA Pharma Inc.
$258
Radius Health, Inc.
$245
Janssen Pharmaceuticals, Inc
$233
BETA BIONICS, INC.
$219
Esperion Therapeutics, Inc.
$196
AbbVie Inc.
$189
Valeritas, Inc.
$179
MannKind Corporation
$174
Zealand Pharma US, Inc.
$161
Medtronic, Inc.
$141
Dexcom, Inc.
$127
Mannkind Corporation
$120
KVK-Tech, Inc.
$110
CeQur Corporation
$106
Endo Pharmaceuticals Inc.
$106
ABBVIE INC.
$99
Madrigal Pharmaceuticals
$98
Currax Pharmaceuticals LLC
$97
Averitas Pharma Inc.
$94
LifeScan, Inc.
$93
Alexion Pharmaceuticals, Inc.
$90
Merck Sharp & Dohme Corporation
$72
RECORDATI_RARE_DISEASES_INC.
$69
Eisai Inc.
$67
Intuity Medical Inc
$60
Merck Sharp & Dohme LLC
$59
GRT US Holding, Inc.
$47
Shire North American Group Inc
$42
Ultragenyx Pharmaceutical Inc.
$41
Embecta Corp.
$40
Ipsen Biopharmaceuticals, Inc
$40
Nalpropion Pharmaceuticals, Inc.
$39
Nevro Corp.
$38
Nalpropion Pharmaceuticals LLC
$33
Orexigen Therapeutics, Inc.
$32
Astellas Pharma US Inc
$30
Amryt Pharma Holdings Ltd
$29
Strongbridge US INC.
$28
DEXCOM, INC.
$27
Daiichi Sankyo Inc.
$24
Genentech USA, Inc.
$22
Neurocrine Biosciences, Inc.
$21
Amphastar Pharmaceuticals, Inc.
$21
LIFESCAN, INC.
$19
Horizon Pharma plc
$17
Antares Pharma, Inc.
$17
Kyowa Kirin, Inc.
$16
Chiesi USA, Inc.
$16
Ascendis Pharma Inc
$15
VIVUS, Inc.
$13
Takeda Pharmaceuticals U.S.A., Inc.
$12
PFIZER INC.
$12
Aytu BioScience, Inc
$11
Top 3 companies account for 83.3% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AVEED · Aimovig · Androgel · BAQSIMI · BD 6cess · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BELSOMRA · BEVESPI AEROSPHERE · BYDUREON · CONTRAVE · CREON · CYCLOSET · Cables · CeQur Simplicity · Creon · Crysvita · DC ACCU-CHEK Diabetes Management Solutions · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · EDEX · ENTRESTO · EVENITY · EYLEA · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · FreeStyle Lite system · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · INJECTAFER · INTELLIS ADAPTIVESTIM · INVOKANA · InPen · JANUVIA · JARDIANCE · KEVEYIS · Kerendia · Kits and Accessories · Korlym · LEQVIO · LICART · LINZESS · LOKELMA · LYRICA · LYUMJEV · Lenvima · MACRILEN · MINIMED 780G · MOUNJARO · MYALEPT · Macrilen · Minimed 670G System · Minimed 770G System · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · NP Thyroid 60 · Natesto · ONETOUCH VERIO REFLECT · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · PENNSAID · PRALUENT · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · QUTENZA · Qutenza · RAYOS · RECORLEV · RESMETIROM · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Senza · Software · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vabysmo · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · iLet Bionic Pancreas · iPro2 · t-slim insulin pump · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for endocrinology in GA.
Geographic Context
Endocrinologists within 10 mi
102
Per 100K population
9.5
County median income
$91,490
Nearest hospital
PIEDMONT HOSPITAL, INC
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Robertson is a mixed practice specialist, with above-average Medicare volume (top 5% in GA), with speaking/promotional industry engagement in the top 1% of GA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Robertson experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Robertson performed 4,020 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Robertson receive payments from pharmaceutical companies?
Yes. Dr. Robertson received a total of $1,590,817 from 80 companies across 2,954 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Robertson's costs compare to other endocrinologists in Atlanta?
Dr. Robertson's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Robertson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Atlanta
Browse endocrinologists in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in GA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in GA
Which GA endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology